Dynamic Interplay between Copper Toxicity and Mitochondrial Dysfunction in Alzheimer's Disease.

Area of Science:

• Neuroscience
• Biochemistry
• Genomics

Background:

• Alzheimer's disease (AD) is a progressive neurodegenerative disorder impacting millions globally, characterized by cognitive decline due to neuronal loss.
• Current treatments for AD are ineffective, highlighting the urgent need for novel therapeutic strategies.
• Proteomics and redox proteomics offer powerful tools to uncover molecular alterations in AD.

Purpose of the Study:

• To review findings from proteomics and redox proteomics in Alzheimer's disease.
• To investigate mitochondrial changes, particularly under oxidative stress and copper exposure.
• To identify potential therapeutic targets for AD drug development.

Main Methods:

• Comparative analysis of proteomics and redox proteomics data from AD studies.
• Focus on alterations in mitochondrial proteins, metabolic pathways, and cellular cascades.
• Evaluation of common mitochondrial proteins implicated in AD pathogenesis.

Main Results:

• Identification of shared alterations in mitochondrial proteins and metabolic pathways in AD.
• Evidence of significant changes in mitochondria under oxidative stress and copper exposure.
• Pinpointed three specific mitochondrial proteins crucial for metabolism, ATP generation, oxidative stress, and apoptosis.

Conclusions:

• The identified mitochondrial proteins represent promising targets for innovative Alzheimer's disease therapies.
• Targeting mitochondria offers a potential avenue for developing new AD treatments.
• Despite challenges, research into mitochondrial-targeted compounds shows encouraging results for AD.